Abnormal lipid rafts related ganglioside expression and signaling in T lymphocytes in immune thrombocytopenia patients

References

• Douglass, A. D., and R. D. Vale. 2005. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121: 937–950
   PubMed Web of Science ®Google Scholar
• Luo, C., K. Wang, Q. Liu de, et al. 2008. The functional roles of lipid rafts in T cell activation, immune diseases and HIV infection and prevention. Cell. Mol. Immunol. 5: 1–7
   PubMed Web of Science ®Google Scholar
• Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387: 569–572
   PubMed Web of Science ®Google Scholar
• Hancock, J. F. 2006. Lipid rafts: contentious only from simplistic standpoints. Nature Rev. Mol. Cell Biol. 7: 456–462
   PubMed Web of Science ®Google Scholar
• Lingwood, D., J. Ries, P. Schwille, and K. Simons. 2008. Plasma membranes are poised for activation of raft phase coalescence at physiological temperature. Proc. Natl. Acad. Sci. USA 105: 10005–10010
   PubMed Web of Science ®Google Scholar
• Hao, M., S. Mukherjee, and F. R. Maxfield. 2001. Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc. Natl. Acad. Sci. USA 98: 13072–13077
   PubMed Web of Science ®Google Scholar
• Kabouridis, P. S., and E. C. Jury. 2008. Lipid rafts and T-lymphocyte function: implications for autoimmunity. FEBS Lett. 582: 3711–3718
   PubMed Web of Science ®Google Scholar
• Shaw, A. R., and L. Li. 2003. Exploration of the functional proteome: lessons from lipid rafts. Curr. Opin. Mol. Ther. 5: 294–301
   PubMed Web of Science ®Google Scholar
• Wollscheid, B., P. D. von Haller, E. Yi, et al. 2004. Lipid raft proteins and their identification in T lymphocytes. Sub-cell. Biochem. 37: 121–152
   PubMedGoogle Scholar
• Campi, G., R. Varma, and M. L. Dustin. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202: 1031–1036
   PubMed Web of Science ®Google Scholar
• von Haller, P. D., S. Donohoe, D. R. Goodlett, et al. 2001. Mass spectrometric characterization of proteins extracted from Jurkat T cell detergent-resistant membrane domains. Proteomics 1: 1010–1021
   PubMed Web of Science ®Google Scholar
• Bini, L., S. Pacini, S. Liberatori, et al. 2003. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem. J. 369: 301–309
   PubMed Web of Science ®Google Scholar
• Razzaq, T. M., P. Ozegbe, E. C. Jury, et al. 2004. Regulation of T-cell receptor signalling by membrane microdomains. Immunology 113: 413–426
   PubMed Web of Science ®Google Scholar
• Mustelin, T., and A. Altman. 1990. Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45). Oncogene 5: 809–813
   PubMed Web of Science ®Google Scholar
• Reynolds, P. J., T. R. Hurley, and B. M. Sefton. 1992. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase. Oncogene 7: 1949–1955
   PubMed Web of Science ®Google Scholar
• Flores-Borja, F., P. S. Kabouridis, E. C. Jury, et al. 2007. Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheumat. 56: 291–302
   PubMed Web of Science ®Google Scholar
• Thomas, M. L., and E. J. Brown. 1999. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol. Today 20: 406–411
   PubMedGoogle Scholar
• Neunert, C., W. Lim, M. Crowther, et al. 2011. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117: 4190–4207
   PubMed Web of Science ®Google Scholar
• Semple, J. W. 2009. Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia. Hematol. Oncol. Clin. North Am. 23: 1177–1192
   PubMed Web of Science ®Google Scholar
• Nomura, S., M. Yanabu, T. Fukuroi, et al. 1992. Anti-glycoprotein IIb/IIIa autoantibodies are reversibly internalized into platelets in idiopathic (autoimmune) thrombocytopenic purpura. Autoimmunity 13: 133–140
   PubMed Web of Science ®Google Scholar
• Nishimoto, T., and M. Kuwana. 2013. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin. Hematol. 50: S43–S49
   PubMedGoogle Scholar
• Zhang, D., H. Li, L. Ma, et al. 2014. The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia. Autoimmunity 47: 519–529
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Z. Chen, H. Li, et al. 2009. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity 42: 112–119
   PubMed Web of Science ®Google Scholar
• Gu, D., J. Ge, W. Du, et al. 2009. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity 42: 692–698
   PubMed Web of Science ®Google Scholar
• Rodeghiero, F., R. Stasi, T. Gernsheimer, et al. 2009. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386–2393
   PubMed Web of Science ®Google Scholar
• Grakoui, A., S. K. Bromley, C. Sumen, et al. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221–227
   PubMed Web of Science ®Google Scholar
• Jury, E. C., P. S. Kabouridis, F. Flores-Borja, et al. 2004. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 113: 1176–1187
   PubMed Web of Science ®Google Scholar
• Freiberg, B. A., H. Kupfer, W. Maslanik, et al. 2002. Staging and resetting T cell activation in SMACs. Nature Immunol. 3: 911–917
   PubMed Web of Science ®Google Scholar
• van der Merwe, P. A. 2001. The TCR triggering puzzle. Immunity 14: 665–668
   PubMed Web of Science ®Google Scholar
• Deng, G. M., and G. C. Tsokos. 2008. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J. Immunol. 181: 4019–4026
   PubMed Web of Science ®Google Scholar
• Krishnan, S., M. P. Nambiar, V. G. Warke, et al. 2004. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172: 7821–7831
   PubMed Web of Science ®Google Scholar
• Gajate, C., F. Gonzalez-Camacho, and F. Mollinedo. 2009. Lipid raft connection between extrinsic and intrinsic apoptotic pathways. Biochem. Biophys. Res. Commun. 380: 780–784
   PubMed Web of Science ®Google Scholar
• Saeki, K., S. Fukuyama, T. Ayada, et al. 2009. A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses. J. Immunol. 182: 5929–5937
   PubMed Web of Science ®Google Scholar
• Saeki, K., Y. Miura, D. Aki, et al. 2003. The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22: 3015–3026
   PubMed Web of Science ®Google Scholar
• McDonald, G., S. Deepak, L. Miguel, et al. 2014. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J. Clin. Invest. 124: 712–724
   PubMed Web of Science ®Google Scholar